uniQure (QURE) Gains from Investment Securities (2015 - 2026)
uniQure (QURE) recorded quarterly Gains from Investment Securities of $242000.0 in Q1 2026, down 74.63% quarter-over-quarter from $954000.0 in Q4 2025, and up 179.08% on a YoY basis from $86712.0 in Q1 2025.
uniQure (QURE) Gains from Investment Securities (2015 - 2026) Analysis & Trends
uniQure's Gains from Investment Securities history runs 12 years deep, the most recent figure standing at $242000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 179.08% year-over-year to $242000.0; the TTM figure through Mar 2026 stood at -$375000.0 (down 532.47% YoY), while the FY2025 annual figure was $4.5 million, down 8.76% from the prior year.
- Gains from Investment Securities was $242000.0 for Q1 2026 at uniQure, down from $954000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.2 million in Q2 2025 to a low of -$2.2 million in Q4 2022.
- Historically, Gains from Investment Securities has averaged $7276.0 across 5 years, with a median of $117997.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities plunged 3425.81% in 2022, then jumped 343.72% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$2.2 million in 2022, then soared by 120.77% to $454000.0 in 2023, then sank by 52.64% to $215000.0 in 2024, then surged by 343.72% to $954000.0 in 2025, then slumped by 74.63% to $242000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $242000.0 (Q1 2026), $954000.0 (Q4 2025), and $118432.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Dec 31, 2025 | 954,000.00 |
| Dec 31, 2025 | 954,000.00 |
| Sep 30, 2025 | 118,432.00 |
| Sep 30, 2025 | 118,432.00 |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 86,712.00 |
| Mar 31, 2025 | 86,712.00 |
| Dec 31, 2024 | 215,000.00 |
| Dec 31, 2024 | 215,000.00 |
| Sep 30, 2024 | 86,712.00 |
| Sep 30, 2024 | 86,712.00 |
| Jun 30, 2024 | -1.79 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | 96,862.00 |
| Mar 31, 2024 | 96,862.00 |
| Dec 31, 2023 | 454,000.00 |
| Dec 31, 2023 | 454,000.00 |